Targedys SAS, of Rouen, France, disclosed a €5.8 million (US$6.5 million) series A round led by Seventure Partners, NCI and Pontifax, to support clinical studies of its products targeting high appetite for treating overweight patients and targeting low appetite for treating malnourishment in elderly people and in patients with cachexia and anorexia.